Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	2,223	2,193	1,897	1,781	1,523	908.63
Other Revenue	19.86	20.57	14.62	17.54	11.12	12.35
Revenue	2,242	2,214	1,912	1,799	1,534	920.98
Revenue Growth (YoY)	14.52%	15.80%	6.29%	17.23%	66.61%	106.07%
Cost of Revenue	1,294	1,293	1,188	1,122	905.42	507.85
Gross Profit	948.58	920.76	724.36	676.98	629.03	413.14
Selling, General & Admin	741.1	728.78	650.14	567.58	458.23	267.36
Operating Expenses	741.1	728.78	650.14	567.58	458.23	267.36
Operating Income	207.49	191.97	74.22	109.4	170.8	145.77
Interest Expense	-18.64	-19.58	-19.85	-25.76	-23.34	-8.01
Earnings From Equity Investments	-1.18	-1.23	-1.59	-2.27	-0.77	-0.08
EBT Excluding Unusual Items	187.67	171.17	52.78	81.37	146.69	137.68
Pretax Income	187.67	171.17	52.78	81.37	146.69	137.68
Income Tax Expense	40.28	35.1	16.16	22.47	19.41	27.2
Earnings From Continuing Operations	147.39	136.07	36.63	58.9	127.29	110.48
Minority Interest in Earnings	-14.75	-13.69	0.02	-8.11	-8.4	-5.27
Net Income	132.64	122.38	36.65	50.79	118.88	105.22
Net Income to Common	132.64	122.38	36.65	50.79	118.88	105.22
Net Income Growth	185.96%	233.93%	-27.84%	-57.28%	12.99%	100.27%
Shares Outstanding (Basic)	605	605	605	605	532	475
Shares Outstanding (Diluted)	605	605	605	605	532	475
Shares Change (YoY)	-	-	-	13.78%	11.97%	1.05%
EPS (Basic)	0.22	0.20	0.06	0.08	0.22	0.22
EPS (Diluted)	0.22	0.20	0.06	0.08	0.22	0.22
EPS Growth	185.96%	233.93%	-27.84%	-62.45%	0.91%	98.19%
Free Cash Flow	132.97	167.33	-59.59	14.96	115.72	-265.73
Free Cash Flow Per Share	0.22	0.28	-0.10	0.03	0.22	-0.56
Dividend Per Share	0.073	0.073	-	0.021	0.111	-
Dividend Growth	-	-	-	-80.69%	-	-
Gross Margin	42.30%	41.59%	37.89%	37.64%	40.99%	44.86%
Operating Margin	9.25%	8.67%	3.88%	6.08%	11.13%	15.83%
Profit Margin	5.92%	5.53%	1.92%	2.82%	7.75%	11.42%
Free Cash Flow Margin	5.93%	7.56%	-3.12%	0.83%	7.54%	-28.85%
EBITDA	282.05	272.49	138.54	167.66	208.7	170.85
EBITDA Margin	12.58%	12.31%	7.25%	9.32%	13.60%	18.55%
D&A For EBITDA	74.56	80.51	64.32	58.25	37.9	25.08
EBIT	207.49	191.97	74.22	109.4	170.8	145.77
EBIT Margin	9.25%	8.67%	3.88%	6.08%	11.13%	15.83%
Effective Tax Rate	21.46%	20.50%	30.61%	27.61%	13.23%	19.75%
Revenue as Reported	2,242	2,214	1,912	1,799	1,534	920.98
Advertising Expenses	-	31.27	93.14	70.61	31.91	41.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.